Axsome Therapeutics (AXSM) Non-Current Debt (2016 - 2026)
Axsome Therapeutics (AXSM) reported Non-Current Debt of $117.96 million for Q2 2026, up 0.4% from $117.54 million a year earlier and up 0.1% from the prior quarter.
Axsome Therapeutics (AXSM) Non-Current Debt (2016 - 2026) Analysis & Trends
At the end of FY2025, Axsome Therapeutics posted Non-Current Debt of $117.75 million, down 34.8% from FY2024.
- Non-Current Debt has a five-year compound annual growth rate of 19.5% (FY2020 to FY2025).
- By year, Non-Current Debt came in at $180.71 million in FY2024 (+1.5%), $178.07 million in FY2023 (+88.9%), $94.26 million in FY2022 (+92.0%) and $49.09 million in FY2021 (+1.6%).
- The Q2 2026 figure ranks as the highest quarterly Non-Current Debt since Q1 2025.
- Year over year, Non-Current Debt gained in four of the last eight quarters, with an average decline of 16.8%.
- The high point for year-over-year Non-Current Debt in five years was Q1 2023 (growth of 199.3%); the low point was Q1 2026 (a decline of 35.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $117.85 million (Q1 2026), $117.75 million (Q4 2025) and $117.64 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Axsome Therapeutics | 8.09 Bn | 6.82 Bn | 204.81 Mn | 117.96 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 117.96 Mn |
| Mar 31, 2026 | 117.85 Mn |
| Dec 31, 2025 | 117.75 Mn |
| Sep 30, 2025 | 117.64 Mn |
| Jun 30, 2025 | 117.54 Mn |
| Mar 31, 2025 | 181.38 Mn |
| Dec 31, 2024 | 180.71 Mn |
| Sep 30, 2024 | 180.00 Mn |
| Jun 30, 2024 | 179.33 Mn |
| Mar 31, 2024 | 178.69 Mn |
| Dec 31, 2023 | 178.07 Mn |
| Sep 30, 2023 | 177.45 Mn |
| Jun 30, 2023 | 176.82 Mn |
| Mar 31, 2023 | 147.62 Mn |
| Dec 31, 2022 | 94.26 Mn |
| Sep 30, 2022 | 93.91 Mn |
| Jun 30, 2022 | 93.46 Mn |
| Mar 31, 2022 | 49.31 Mn |
| Dec 31, 2021 | 49.09 Mn |
| Sep 30, 2021 | 49.17 Mn |
Axsome Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=AXSM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();